Associations among Physician-Patient Communication, Patient Satisfaction, and Clinical Effectiveness of Overactive Bladder Medication: A Survey of Patients with Overactive Bladder

被引:8
作者
Izumi, Naoko [1 ]
Matsuo, Tomohiro [2 ]
Matsukawa, Yoshihisa [3 ]
机构
[1] Pfizer Japan Inc, Med Affairs, Internal Med, 3-22-7 Yoyogi,Shibuya ku, Tokyo 1518589, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki 8528501, Japan
[3] Nagoya Univ, Dept Urol, Grad Sch Med, Nagoya, Aichi 4668550, Japan
关键词
urinary bladder; overactive; communication; medication adherence; physician-patient relations; surveys and questionnaires; ADHERENCE; ONSET;
D O I
10.3390/jcm11144087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This cross-sectional survey study evaluated associations between physician-patient communication and patient satisfaction with overactive bladder (OAB) medical care or clinical effectiveness. Japanese patients aged >= 50 years with OAB who had taken OAB medication within 2 years received a web-based survey regarding OAB medical care, physician-patient communication on OAB symptoms and treatment, and OAB symptom score (OABSS) change with treatment. Associations between physician-patient communication and patient satisfaction or OAB medication effectiveness (>= 3-point improvement in OABSS) were investigated by multivariate analysis with confounding factors. Stratified analyses were performed based on medication continuation or discontinuation (for reasons except symptom improvement). Of the 1004 respondents included in the analyses, 58.0% continued treatment, and 23.7% discontinued for reasons except symptom improvement. Satisfaction with OAB care was associated with reported effectiveness, medication side effects, physician-patient communication, and whether medication was switched. Medication effectiveness was associated with patient-physician communication, female sex, and not switching medication. Significantly more patients in the continuation group were satisfied and had improvement of >= 3 points in OABSS (p < 0.001 for both). The findings suggest that, in Japan, adequate physician-patient communication contributes significantly to improving clinical effectiveness and satisfaction with medical care in OAB patients as well as treatment continuation.
引用
收藏
页数:14
相关论文
共 18 条
[1]  
Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
[2]  
American Urological Association, DIAGN TREATM NONN OV
[3]   Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder [J].
Chapple, Christopher R. ;
Nitti, Victor W. ;
Khullar, Vik ;
Wyndaele, Jean Jacques ;
Herschorn, Sender ;
van Kerrebroeck, Philip ;
Blauwet, Mary Beth ;
Siddiqui, Emad .
WORLD JOURNAL OF UROLOGY, 2014, 32 (06) :1565-1572
[4]   Impact of overactive bladder on women in the United States: results of a national survey [J].
Dmochowski, Roger R. ;
Newman, Diane K. .
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (01) :64-75
[5]   The patient perspective on overactive bladder: a mixed-methods needs assessment [J].
Filipetto, Frank A. ;
Fulda, Kimberly G. ;
Holthusen, Amy E. ;
McKeithen, Thomas M. ;
McFadden, Pam .
BMC FAMILY PRACTICE, 2014, 15
[6]   Responsiveness and Minimal Clinically Important Change in Overactive Bladder Symptom Score [J].
Gotoh, Momokazu ;
Homma, Yukio ;
Yokoyama, Osamu ;
Nishizawa, Osamu .
UROLOGY, 2011, 78 (04) :768-773
[7]   Physician-patient communication about overactive bladder: Results of an observational sociolinguistic study [J].
Hahn, Steven R. ;
Bradt, Pamela ;
Hewett, Kathleen A. ;
Ng, Daniel B. .
PLOS ONE, 2017, 12 (11)
[8]   An epidemiological survey of overactive bladder symptoms in Japan [J].
Homma, Y ;
Yamaguchi, O ;
Hayashi, K .
BJU INTERNATIONAL, 2005, 96 (09) :1314-1318
[9]   Symptom assessment tool for overactive bladder syndrome- Overactive bladder symptom score [J].
Homma, Yukio ;
Yoshida, Masaki ;
Seki, Narihito ;
Yokoyama, Osamu ;
Kakizaki, Hidehiro ;
Gotoh, Momokazu ;
Yamanishi, Tomonori ;
Yamaguchi, Osamu ;
Takeda, Masayuki ;
Nishizawa, Osamu .
UROLOGY, 2006, 68 (02) :318-323
[10]   Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand? [J].
Marcelissen, Tom ;
Rashid, Tina ;
Lopes, Tiago Antunes ;
Delongchamps, Nicolas Barry ;
Geavlete, Bogdan ;
Rieken, Malte ;
Cornu, Jean-Nicolas ;
Rahnama'i, Mohammad Sajjad .
EUROPEAN UROLOGY FOCUS, 2019, 5 (06) :1112-1119